The Pharmaceutical Form-Fill-Seal Association Of India Profile
Key Indicators
- Company Age 28 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -2.94%
(FY 2022)
- Profit -43.71%
(FY 2022)
- Ebitda -33.16%
(FY 2022)
- Net Worth 5.40%
(FY 2022)
- Total Assets 4.07%
(FY 2022)
About The Pharmaceutical Form-Fill-Seal Association Of India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Vijay Walia, Neeta Karkhanis, Shailesh Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100MH1996NPL100174
- Company No.
100174
- Company Classification
Public Not For Profit Company
- Incorporation Date
12 Jun 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at The Pharmaceutical Form-Fill-Seal Association Of India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Walia  | Director | 17-Sep-2018 | Current |
| Neeta Karkhanis | Director | 28-Sep-2018 | Current |
| Shailesh Shah | Additional Director | 01-Jun-2022 | Current |
| Bhavesh Girishbhai | Director | 29-Sep-2010 | Current |
Financial Performance and Corporate Structure Insights of The Pharmaceutical Form-Fill-Seal Association Of India.
The Pharmaceutical Form-Fill-Seal Association Of India, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.94% decrease. The company also saw a substantial fall in profitability, with a 43.71% decrease in profit. The company's net worth moved up by a moderate rise of 5.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of The Pharmaceutical Form-Fill-Seal Association Of India?
Unlock access to The Pharmaceutical Form-Fill-Seal Association Of India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at The Pharmaceutical Form-Fill-Seal Association Of India?
Unlock and access historical data on people associated with The Pharmaceutical Form-Fill-Seal Association Of India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of The Pharmaceutical Form-Fill-Seal Association Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped The Pharmaceutical Form-Fill-Seal Association Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
